SG
NGM
StepStone Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,573,357
| Closed | -$2.5M | – | 23 |
|
|
2024
Q1 | $2.5M | Hold |
1,573,357
| – | – | 0.53% | 13 |
|
|
2023
Q4 | $1.35M | Hold |
1,573,357
| – | – | 0.24% | 14 |
|
|
2023
Q3 | $1.68M | Hold |
1,573,357
| – | – | 0.38% | 13 |
|
|
2023
Q2 | $4.07M | Hold |
1,573,357
| – | – | 0.75% | 11 |
|
|
2023
Q1 | $7.9M | Hold |
1,573,357
| – | – | 1.47% | 10 |
|
|
2022
Q4 | $7.9M | Hold |
1,573,357
| – | – | 1.03% | 13 |
|
|
2022
Q3 | $20.6M | Hold |
1,573,357
| – | – | 2.93% | 8 |
|
|
2022
Q2 | $20.2M | Hold |
1,573,357
| – | – | 2.16% | 9 |
|
|
2022
Q1 | $24M | Hold |
1,573,357
| – | – | 1.79% | 11 |
|
|
2021
Q4 | $27.9M | Hold |
1,573,357
| – | – | 1.59% | 10 |
|
|
2021
Q3 | $33.1M | Buy |
+1,573,357
| New | +$33.1M | 2.14% | 8 |
|